Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2023 | Story Reuben Maeko | Photo SUPPLIED
Dr Tabane
Dr Lizzy Tabane, Head of Paediatrics and Child Health in the Faculty of Health Sciences at the University of the Free State, gives a message of support at the 2023 SAPA Conference.

The Department of Paediatrics and Child Health at the University of the Free State (UFS) recently hosted the 2023 South African Paediatric Association conference (SAPA) in Sandton, Johannesburg, with more than 200 doctors, specialists and registrars in attendance. 

The conference aimed to provide high-quality, evidence-based updates on children’s health issues and research in health care. The three-day conference focused on presentations from various paediatricians in South Africa’s health sectors.

Conference presentations 

The conference explored new ways of treating different types of childhood diseases, and covered a range of topics such as learning disabilities and inclusive education, sports for children with asthma, septic shock, dyslipidaemia in children, congenital heart disease among others.

Collaborations with healthcare professionals

Head of Paediatrics and Child Health at the UFS, Dr Lizzy Tabane and her colleagues, Dr Mampoi Jonas and Prof Ute Hallbauer, were pleased with the success and outcome of the conference. 

According to Dr Tabane, the professionals gather once a year to learn, exchange ideas and work together to ensure the best possible care for children in hospitals. 

“The SAPA conference presents health professionals across South Africa with the latest information on paediatric health. It also ensures that children in our country continue to receive quality care through an integrated approach by allowing health professionals to connect, network, and share their knowledge and expertise,” said Dr Jonas.

“The country and the community at large are in good hands,” said Dr Tabane. “Let us not fall behind but catch up with the latest innovations, for instance, Artificial Intelligence and Machine Learning in Medicine. Our partnership with all paediatrics and other health professionals will bring unity and good child health care in our country."

“What is important is the tremendous support from all the specialists, doctors and practice nurses from different health-care departments who have consistently turned out in large numbers. The success of the conference extends beyond GPs, such as drawing in specialists, clinicians, nurses, and professionals dedicated to children’s well-being within hospitals and the community,” emphasised Dr Tabane.

Significance of the conference

Prof Hallbauer emphasised the significance of fostering collaboration to enhance integrated care, spanning both the hospital system and primary care. “This annual conference confirms our commitment to working together as doctors for the well-being of our patients. The motto we have chosen is Carpe Diem ‘Seize the Day’. For the conference this means taking hold of the programme and making the most of each conference day. 

“When you meet your colleagues, build and strengthen the collegial networks, so that we can realise Letshwele le beta phoho – a SeSotho idiom meaning ‘The crowd beats the bull’,” added Prof Hallbauer. 

This conference “will strengthen our relationship” with other doctors and make the health system a better place, concluded Prof Hallbauer. 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept